Loading clinical trials...
Loading clinical trials...
Due to different etiologies, diagnosis and treatment of HCC in China is different from that in Western countries.US is an important screening method for HCC in patients with liver cirrhosis. CEUS, as ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tianjin Third Central Hospital
Collaborators
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
NCT07439939 · Liver Cirrhosis, Portal Hypertension
NCT07466602 · Primary Liver Cancer
NCT06345508 · Hepatocellular Carcinoma, Liver Cancer
NCT06680583 · Liver Cirrhosis, Gastrointestinal Bleeding
Tianjin Third Central Hospital
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions